Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant.
Trainer, P J
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. [electronic resource] - The New England journal of medicine Apr 2000 - 1171-7 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0028-4793
10.1056/NEJM200004203421604 doi
Acromegaly--blood
Adenoma--drug therapy
Adult
Autoantibodies--blood
Double-Blind Method
Female
Human Growth Hormone--adverse effects
Humans
Insulin-Like Growth Factor I--metabolism
Male
Middle Aged
Pituitary Neoplasms--drug therapy
Receptors, Somatotropin--antagonists & inhibitors
Treatment of acromegaly with the growth hormone-receptor antagonist pegvisomant. [electronic resource] - The New England journal of medicine Apr 2000 - 1171-7 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0028-4793
10.1056/NEJM200004203421604 doi
Acromegaly--blood
Adenoma--drug therapy
Adult
Autoantibodies--blood
Double-Blind Method
Female
Human Growth Hormone--adverse effects
Humans
Insulin-Like Growth Factor I--metabolism
Male
Middle Aged
Pituitary Neoplasms--drug therapy
Receptors, Somatotropin--antagonists & inhibitors